Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia
May 2007
Invega (paliperidone) is being promoted as a new atypical antipsychotic for schizophrenia.
But the ingredient in Invega is not really that new...it's the active metabolite of risperidone (Risperdal).
Expect Invega to work as well as risperidone, and have similar side effects such as restlessness or extrapyramidal symptoms.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote